March 2, 2026 · Form 4 insider transaction
Paolini John F. sold 5,714 shares of Kiniksa Pharmaceuticals Ltd. at $45.92 per share, a transaction worth $262.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.56 and $46.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.